Skip to main content

atHeart Medical is hiring an experienced and highly collaborative Head of Therapy Development in the USA. The Head of Therapy Development will drive stakeholders’ engagement and market readiness throughout the US pivotal clinical trial program and beyond.

This role will be key in the atHeart Medical matrix, connecting with Clinical Affairs and R&D, and driving marketing activities to support the reSept ASD Occluder’s value proposition.

The Head of Therapy Development is US-based, can work remotely and spends significant time travelling. For a full job description, please view our job opening on Lifeblood.  For any further questions regarding this position, please contact Marina Lohri.

atHeart Medical was founded to establish the first transcatheter septal occluder with a metal-free frame, as the new standard of care for atrial septal defects (ASD). We want patients with ASDs to be treated with a device that keeps more transeptal treatment options open for their future. Our name embeds our values: in everything we do, we have clinical excellence and patients at heart.

We are conducting the US FDA-approved ASCENT ASD pivotal trial in the USA and in Europe. The trial investigates the safety and efficacy of our reSept ASD Occluder to treat patients with clinically significant, isolated ASD.